» Articles » PMID: 33128270

Cardiac Arrhythmias Amongst Hospitalised Coronavirus 2019 (COVID-19) Patients: Prevalence, Characterisation, and Clinical Algorithm to Classify Arrhythmic Risk

Overview
Publisher Wiley
Specialty General Medicine
Date 2020 Oct 31
PMID 33128270
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: A significant proportion of COVID-19 patients may have cardiac involvement including arrhythmias. Although arrhythmia characterisation and possible predictors were previously reported, there are conflicting data regarding the exact prevalence of arrhythmias. Clinically applicable algorithms to classify COVID patients' arrhythmic risk are still lacking, and are the aim of our study.

Methods: We describe a single-centre cohort of hospitalised patients with a positive nasopharyngeal swab for COVID-19 during the initial Israeli outbreak between 1/2/2020 and 30/5/2020. The study's outcome was any documented arrhythmia during hospitalisation, based on daily physical examination, routine ECG's, periodic 24-hour Holter, and continuous monitoring. Multivariate analysis was used to find predictors for new arrhythmias and create classification trees for discriminating patients with high and low arrhythmic risk.

Results: Out of 390 COVID-19 patients included, 28 (7.2%) had documented arrhythmias during hospitalisation, including 23 atrial tachyarrhythmias, combined atrial fibrillation (AF), and ventricular fibrillation, ventricular tachycardia storm, and 3 bradyarrhythmias. Only 7/28 patients had previous arrhythmias. Our study showed a significant correlation between disease severity and arrhythmia prevalence (P < .001) with a low arrhythmic prevalence amongst mild disease patients (2%). Multivariate analysis revealed background heart failure (CHF) and disease severity are independently associated with overall arrhythmia while age, CHF, disease severity, and arrhythmic symptoms are associated with tachyarrhythmias. A novel decision tree using age, disease severity, CHF, and troponin levels was created to stratify patients into high and low risk for developing arrhythmia.

Conclusions: Dominant arrhythmia amongst COVID-19 patients is AF. Arrhythmia prevalence is associated with age, disease severity, CHF, and troponin levels. A novel simple Classification tree, based on these parameters, can discriminate between high and low arrhythmic risk patients.

Citing Articles

A pooled analysis of the incidence and mortality risk of atrial fibrillation in patients with COVID-19.

Shen N, Wang J, Liu X, Fu Y, Chen X PeerJ. 2024; 12:e18330.

PMID: 39430559 PMC: 11490229. DOI: 10.7717/peerj.18330.


Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia.

Maisano A, Vitolo M, Imberti J, Bonini N, Albini A, Valenti A Rev Cardiovasc Med. 2024; 23(5):176.

PMID: 39077611 PMC: 11273968. DOI: 10.31083/j.rcm2305176.


Fibrinaloid Microclots and Atrial Fibrillation.

Kell D, Lip G, Pretorius E Biomedicines. 2024; 12(4).

PMID: 38672245 PMC: 11048249. DOI: 10.3390/biomedicines12040891.


Symptomatic Ventricular Bigeminy and Trigeminy Associated With COVID-19.

Hu J, Phan A, Oganesian B, Kim H Cureus. 2023; 15(5):e38650.

PMID: 37288241 PMC: 10241988. DOI: 10.7759/cureus.38650.


Long-Term Mortality after New-Onset Atrial Fibrillation in COVID-19.

Jurisic S, Komminoth M, Todorov A, Bertschi D, Jurisic M, Vranjic I J Clin Med. 2023; 12(8).

PMID: 37109261 PMC: 10146060. DOI: 10.3390/jcm12082925.